Cholesterol and serotonin transporter polymorphism interactions in late-life depression

Neurobiology of Aging

Volumn 32, Issue 2, 2011, Pages 336-343

  Kim, Jae Min ^a   Stewart, Robert ^b   Kim, Sung Wan ^a   Shin, Il Seon ^a   Yang, Su Jin ^a   Yoon, Jin Sang ^a  

^a Chonnam National University Medical School   (South Korea)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Aged; Cholesterol; Depression; Gene environment interaction; HDL cholesterol; Serotonin transporter

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SEROTONIN TRANSPORTER; TRIACYLGLYCEROL;

AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DEPRESSION; FEMALE; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PROMOTER REGION; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CHOLESTEROL; DEPRESSION; FEMALE; GENE FREQUENCY; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; LIFE CHANGE EVENTS; MALE; POLYMORPHISM, GENETIC; PREVALENCE; PROMOTER REGIONS, GENETIC; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; RESIDENCE CHARACTERISTICS; RISK FACTORS; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS;

EID: 77955554817     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2009.02.017     Document Type: Article

References (43)

1. Aijänseppä S., Kivinen P., Helkala E.L., Kivelä S.L., Tuomilehto J., Nissinen A. Serum cholesterol and depressive symptoms in elderly Finnish men. Int. J. Geriatr. Psychiatry 2002, 17(7):629-634.
2. Alexopoulos G.S., Meyers B.S., Young R.C., Campbell S., Sibersweig D., Charlson M. 'Vascular depression' hypothesis. Arch. Gen. Psychiatry 1997, 54(10):915-922.
3. Buydens-Branchey L., Branchey M., Hudson J., Fergeson P. Low HDL cholesterol, aggression and altered central serotonergic activity. Psychiatry Res. 2000, 93(2):93-102.
4. Camus V., Kraehenbühl H., Preisig M., Büla C.J., Waeber G. Geriatric depression and vascular diseases: what are the links?. J. Affect. Disord. 2004, 81(1):1-16.
5. Chen R., Hu Z., Qin X., Xu X., Copeland J.R. A community-based study of depression in older people in Hefei, China-the GMS-AGECAT prevalence, case validation and socio-economic correlates. Int. J. Geriatr. Psychiatry 2004, 19(5):407-413.
6. Chong M.Y., Tsang H.Y., Chen C.S., Tang T.C., Chen C.C., Yeh T.L., Lee Y.H., Lo H.Y. Community study of depression in Taiwan: prevalence, life events and socio-demographic correlates. Br. J. Psychiatry 2001, 178(1):29-35.
7. Comings D.E., MacMurray J.P., Gonzalez N., Ferry L., Peters W.R. Association of the serotonin transporter gene with serum cholesterol levels and heart disease. Mol. Genet. Metab. 1999, 67(3):248-253.
8. Copeland J.R.M., Dewey M.E., Griffiths-Jones H.M. A computerized psychiatric diagnostic system and case nomenclature for elderly subjects: GMS and AGECAT. Psychol. Med. 1986, 16(1):89-99.
9. Copeland J.R.M., Dewey M.E., Saunders P. The epidemiology of dementia: GMS-AGECAT studies of prevalence and incidence, including studies in progress. Eur. Arch. Psychiatry Clin. Neurosci. 1991, 240(4-5):212-217.
10. Copeland J.R.M., Beekman A.T., Dewey M.E., Hooijer C., Jordan A., Lawlor B.A., Lobo A., Magnusson H., Mann A.H., Meller I., Prince M.J., Reischies F., Turrina C., deVries M.W., Wilson K.C. Depression in Europe. Geographical distribution among older people. Br. J. Psychiatry 1999, 174:312-321.
11. Dimopoulos N., Piperi C., Salonicioti A., Psarra V., Mitsonis C., Liappas I., Lea R.W., Kalofoutis A. Characterization of the lipid profile in dementia and depression in the elderly. J. Geriatr. Psychiatry Neurol. 2007, 20(3):138-144.
12. Edenberg H.J., Reynolds J. Improved method for detecting the long and short promoter alleles of the serotonin transporter gene HTT (SLC6A4). Psychiatr. Genet. 1998, 8(3):193-195.
13. Engelberg H. Low serum cholesterol and suicide. Lancet 1992, 339(8795):727-729.
14. Fischer P., Gruenblatt E., Pietschmann P., Tragl K.H. Serotonin transporter polymorphism and LDL-cholesterol. Mol. Psychiatry 2006, 11(8):707-709.
15. Greenberg B.D., Tolliver T.J., Huang S.J., Li Q., Bengel D., Murphy D.L. Genetic variation in the serotonin transporter promoter region affects serotonin uptake in human blood platelets. Am. J. Med. Genet. 1999, 88(1):83-87.
16. Ha T.M., Cho D.M., Park S.W., Joo M.J., Lee B.J., Kong B.G., Kim J.M., Yoon J.S., Kim Y.H. Evaluating associations between 5-HTTLPR polymorphism and Alzheimer's disease for Korean patients. Dement. Geriatr. Cogn. Disord. 2005, 20(1):31-34.
17. Heils A., Teufel A., Petri S., Seemann M., Bengel D., Balling U., Riederer P., Lesch K.P. Functional promoter and polyadenylation site mapping of the human serotonin (5-HT) transporter gene. J. Neural. Transm. Gen. Sect. 1995, 102(3):247-254.
18. Heinz A., Jones D.W., Mazzanti C., Goldman D., Ragan P., Hommer D., Linnoila M., Weinberger D.R. A relationship between serotonin transporter genotype and in vivo protein expression and alcohol neurotoxicity. Biol. Psychiatry 2000, 47(7):643-649.
19. Kendler K.S., Kuhn J.W., Vittum J., Prescott C.A., Riley B. The interaction of stressful life events and a serotonin transporter polymorphism in the prediction of episodes of major depression. Arch. Gen. Psychiatry 2005, 62(5):529-535.
20. Kim J.M., Stewart R., Glozier N., Prince M., Kim S.W., Yang S.J., Shin I.S., Yoon J.S. Physical health, depression and cognitive function as correlates of disability in an older Korean population. Int. J. Geriatr. Psychiatry 2005, 20(2):160-167.
21. Kim J.M., Stewart R., Kim S.W., Shin I.S., Yang S.J., Yoon J.S. Vascular risk factors and incident late-life depression in a Korean population. Br. J. Psychiatry 2006, 189:26-30.
22. Kim J.M., Stewart R., Kim S.W., Yang S.J., Shin I.S., Kim Y.H., Yoon J.S. Interactions between life stressors and susceptibility genes (5-HTTLPR and BDNF) on depression in Korean elders. Biol. Psychiatry 2007, 62(5):423-428.
23. Kim J.M., Stewart R., Kim S.W., Yang S.J., Shin I.S., Kim Y.H., Yoon J.S. BDNF genotype potentially modifying the association between incident stroke and depression. Neurobiol. Aging 2008, 29(5):789-792.
24. Kim J.M., Stewart R., Prince M., Shin I.S., Yoon J.S. Diagnosing dementia in a developing nation: an evaluation of the GMS-AGECAT algorithm in an older Korean population. Int. J. Geriatr. Psychiatry 2003, 18(4):331-336.
25. Kim J.M., Stewart R., Shin I.S., Yoon J.S. Vascular disease/risk and late-life depression in a Korean community population. Br. J. Psychiatry 2004, 185:102-107.
26. Ko M., Kim M.T., Nam J.J. Assessing risk factors of coronary heart disease and its risk prediction among Korean adults: the 2001 Korea National Health and Nutrition Examination Survey. Int. J. Cardiol. 2006, 110(2):184-190.
27. Kubo M., Kiyohara Y., Kato I., Tanizaki Y., Arima H., Tanaka K., Nakamura H., Okubo K., Iida M. Trends in the incidence, mortality, and survival rate of cardiovascular disease in a Japanese community: the Hisayama study. Stroke 2003, 34(10):2349-2354.
28. Kuh E.H. A community study of mental disorders in elderly Singaporean Chinese using the GMS-AGECAT package. Aust. N. Z. J. Psychiatry 1992, 26(3):502-506.
29. Lehto S.M., Hintikka J., Niskanen L., Tolmunen T., Koivumaa-Honkanen H., Honkalampi K., Viinamäki H. Low HDL cholesterol associates with major depression in a sample with a 7-year history of depressive symptoms. Prog. Neuropsychopharmacol. Biol. Psychiatry 2008, 32(6):1557-1561.
30. Lesch K.P., Bengel D., Heils A., Sabol S.Z., Greenberg B.D., Petri S., Benjamin J., Müller C.R., Hamer D.H., Murphy D.L. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996, 274(5292):1527-1531.
31. Llibre Rodriguez J.J., Ferri C.P., Acosta D., Guerra M., Huang Y., Jacob K.S., Krishnamoorthy E.S., Salas A., Sosa A.L., Acosta I., Dewey M.E., Gaona C., Jotheeswaran A.T., Li S., Rodriguez D., Rodriguez G., Kumar P.S., Valhuerdi A., Prince M. Prevalence of dementia in Latin America, India, and China: a population-based cross-sectional survey. Lancet 2008, 372(9637):464-474. 10/66 Dementia Research Group.
32. Morgan R.E., Palinkas L.A., Barrett-Connor E.L., Wingard D.L. Plasma cholesterol and depressive symptoms in older men. Lancet 1993, 341(8837):75-79.
33. Mottram P., Wilson K., Copeland J. Validation of the Hamilton Depression Rating Scale and Montgommery and Asberg Rating Scales in terms of AGECAT depression cases. Int. J. Geriatr. Psychiatry 2000, 15(12):1113-1119.
34. Nakatani D., Sato H., Sakata Y., Shiotani I., Kinjo K., Mizuno H., Shimizu M., Ito H., Koretsune Y., Hirayama A., Hori M. Influence of serotonin transporter gene polymorphism on depressive symptoms and new cardiac events after acute myocardial infarction. Am. Heart J. 2005, 150(4):652-658. Osaka Acute Coronary Insufficiency Study Group.
35. Ogilvie A.D., Battersby S., Bubb V.J., Fink G., Harmar A.J., Goodwim G.M., Smith C.A. Polymorphism in serotonin transporter gene associated with susceptibility to major depression. Lancet 1996, 347(9003):731-733.
36. Otte C., McCaffery J., Ali S., Whooley M.A. Association of a serotonin transporter polymorphism (5-HTTLPR) with depression, perceived stress, and norepinephrine in patients with coronary disease: the Heart and Soul Study. Am. J. Psychiatry 2007, 164(9):1379-1384.
37. Papakostas G.I., Petersen T., Mischoulon D., Hughes M.E., Alpert J.E., Nierenberg A.A., Rosenbaum J.F., Fava M. Serum cholesterol and serotonergic function in major depressive disorder. Psychiatry Res. 2003, 118(2):137-145.
38. Park J.H., Kwon Y.C. Modification of the mini-mental state examination for use in the elderly in a non-western society: Part I. Development of Korean version of Mini-Mental State Examination. Int. J. Geriatr. Psychiatry 1990, 5:381-387.
39. Prince M., Acosta D., Chiu H., Scazufca M., Varghese M. Dementia diagnosis in developing countries: a cross-cultural validation study. Lancet 2003, 361(9361):909-917. 10/66 Dementia Research Group.
40. Ramasubbu R., Tobias R., Buchan A.M., Bech-Hansen N.T. Serotonin transporter gene promoter region polymorphism associated with poststroke major depression. J. Neuropsychiatry Clin. Neurosci. 2006, 18(1):96-99.
41. Sarchiapone M., Camardese G., Roy A., Della Casa S., Satta M.A., Gonzalez B., Berman J., De Risio S. Cholesterol and serotonin indices in depressed and suicidal patients. J. Affect. Disord. 2001, 62(3):217-219.
42. Terao T., Nakamura J., Yoshimura R., Ohmori O., Takahashi N., Kojima H., Soeda S., Shinkai T., Nakano H., Okuno T. Relationship between serum cholesterol levels and meta-chlorophenylpiperazine-induced cortisol responses in healthy men and women. Psychiatry Res. 2000, 96(2):167-173.
43. Zhang X., Patel A., Horibe H., Wu Z., Barzi F., Rodgers A., MacMahon S., Woodward M. Cholesterol, coronary heart disease, and stroke in the Asia Pacific region. Int. J. Epidemiol. 2003, 32(4):563-572. Asia Pacific Cohort Studies Collaboration.